Northwestern Medicine Launches COVID-19 Drug Trial

Remdesivir COVID-19 Coronavirus

Remdesivir was developed for Ebola and has antiviral activity for coronaviruses. Northwestern Medicine has enrolled its first participants in a new international clinical drug trial for...

The post Northwestern Medicine Launches COVID-19 Drug Trial appeared first on SciTechDaily.



from SciTechDaily https://ift.tt/2V6tEWO

Post a Comment

0 Comments